NCT00982657 2015-11-20A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell CarcinomaPfizerPhase 2 Terminated34 enrolled 10 charts
NCT00729833 2014-06-09Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid TumorsPfizerPhase 1 Terminated45 enrolled 18 charts